Skip to main content
. 2014 Mar 3;10:535–543. doi: 10.3762/bjoc.10.49

Scheme 3.

Scheme 3

Strategies for introducing linker-based thiol groups to the aromatic moiety of ansamitocin P-3 for accessing tumor targeting conjugates (CuAAC; Cu-mediated azide–alkyne cycloaddition).